021-51111890
购物车（）
sales@molnova.cn
首页-
Products -
Others -
Other Targets -
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
CAS No. 288154-16-5
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester ( —— )
产品货号. M35774 CAS No. 288154-16-5
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester is a biologically active compound used as an intermediate in the synthesis of a variety of compounds.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥114 | 有现货 |
|
| 10MG | ￥171 | 有现货 |
|
| 25MG | ￥287 | 有现货 |
|
| 50MG | ￥425 | 有现货 |
|
| 100MG | ￥624 | 有现货 |
|
| 500MG | ￥1557 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥116 | 有现货 |
|
生物学信息
-
产品名称4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester is a biologically active compound used as an intermediate in the synthesis of a variety of compounds.
-
产品描述4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester is a biologically active compound used as an intermediate in the synthesis of a variety of compounds.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number288154-16-5
-
分子量378.42
-
分子式C19H26N2O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)(C)OC(=O)N1CCC(CC1)(NC(=O)OCc1ccccc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
DL-Menthol
DL-Menthol has short term toxicity in rats, it plays a role in the induction of surgical anesthesia in fishes, related at least in part to the activation of GABAA receptors.
-
Spiramycin
由安博法链霉菌 (Streptomyces ambofaciens) 产生的大环内酯类抗生素。
-
4-Methoxycinnamaldeh...
4-Methoxycinnamaldehyde is an active ingredient of Agastache rugosa.4-Methoxycinnamaldehyde has cytoprotective activity against respiratory syncytial virus (RSV) in human laryngeal carcinoma cell lines, and helps to control disease induced by RSV infection, with an IC50 of approximately 0.055 μg/mL. The IC50 was about 0.055 μg/mL.
